Corona Remedies
15 Dec '25MAINBOARD
Min. Investment
₹14,112
Issue size
₹655.37 Cr
GMP
Locked
Overall subscription: 134.63x
Check allotment status
Expert verdict
IPO dates
08 Dec
Opening
10 Dec
Closing
11 Dec
Allotment
15 Dec
Listing
*Refunds will be initiated on 12 Dec '25
IPO quota
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 14 | ₹14,868 |
| HNI (Min) | 14 | 196 | ₹2,08,152 |
Subscription (as on 14 March 2026, 08:30 AM)
Overall134.63x
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
Founded: 2004|MD: Mr Niravkumar Kirtikumar Mehta
- Corona Remedies Limited is an India-focused branded pharmaceutical formulations company engaged in developing, manufacturing, and marketing products in various therapeutic areas. These include women's healthcare, cardiology, diabetology, pain management, and urology.
- The company operates two manufacturing facilities—one in Bhayla, Gujarat, and another in Solan, Himachal Pradesh. As of June 30, 2025, the company’s manufacturing facilities had an aggregated installed capacity of 128.54 crore units per annum and 11 production lines.
- The company also operates two research and development (R&D) facilities in India, which are housed within its manufacturing facilities and registered with the Department of Scientific and Industrial Research, Ministry of Science and Technology. As of June 30, 2025, the company employed 103 staff members in its R&D department.
Issue Details & Objective
Lot size
14 Shares
Price band
₹1008 to 1062
Face value
₹10 per share
Financials
IPO reservation
QIB - 49.53%
Retail - 34.67%
Download DRHP (IPO Doc)FAQs
Should I apply for the Corona Remedies IPO?
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
What is the issue size of Corona Remedies IPO?
The issue size of Corona Remedies IPO is ₹655.37 Cr
What are the open and close dates for Corona Remedies IPO?
The Corona Remedies IPO will be open for applications from 08 Dec '25 to 10 Dec '25
What is the lot size and minimum order quantity of Corona Remedies IPO?
The lot size of Corona Remedies IPO is 14 Shares and its minimum investment amount is ₹14,112.
What is the GMP value of Corona Remedies IPO?
Grey market premium (GMP) is a premium amount at which grey market IPO shares are traded before they get listed in the stock exchange. The GMP for Corona Remedies IPO is 24.48
